|
1
|
Tinkle CL and Haas-Kogen D: Hepatocellular
carcinoma: Natural history, current management, and emerging tools.
Biologics. 6:207–219. 2012.PubMed/NCBI
|
|
2
|
Marquardt JU and Thorgeirsson SS:
SnapShot: Hepatocelluar carcinoma. Cancer Cell. 25:550.e12014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takai A, Dang HT and Wang XW:
Identification of drivers from cancer genome diversity in
hepatocellular carcinoma. Int J Mol Sci. 15:11142–11160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pinyol R, Nault JC, Quetglas IM,
Zucman-Rossi J and Llovet JM: Molecular profiling of liver tumors:
Classification and clinical translation for decision making. Semin
Liver Dis. 34:363–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moinzadeh P, Breuhahn K, Stützer H and
Schirmacher P: Chromosome alterations in human hepatocellular
carcinomas correlate with aetiology and histological grade -
results of an explorative CGH meta-analysis. Br J Cancer.
92:935–941. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chochi Y, Kawauchi S, Nakao M, Furuya T,
Hashimoto K, Oga A, Oka M and Sasaki K: A copy number gain of the
6p arm is linked with advanced hepatocellular carcinoma: An
array-based comparative genomic hybridization study. J Pathol.
217:677–684. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katoh H, Ojima H, Kokubu A, Saito S, Kondo
T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S and Shibata
T: Genetically distinct and clinically relevant classification of
hepatocellular carcinoma: Putative therapeutic targets.
Gastroenterology. 133:1475–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB,
Thorgeirsson SS and Popescu NC: Cloning, characterization, and
chromosomal localization of a gene frequently deleted in human
liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res.
58:2196–2199. 1998.PubMed/NCBI
|
|
9
|
Neel BG, Jhanwar SC, Chaganti RS and
Hayward WS: Two human c-onc genes are located on the long arm of
chromosome 8. Proc Natl Acad Sci USA. 79:7842–7846. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Durkin ME, Yuan BZ, Zhou X, Zimonjic DB,
Lowy DR, Thorgeirsson SS and Popescu NC: DLC-1: A Rho
GTPase-activating protein and tumour suppressor. J Cell Mol Med.
11:1185–1207. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lukasik D, Wilczek E, Wasiutynski A and
Gornicka B: Deleted in liver cancer protein family in human
malignancies (Review). Oncol Lett. 2:763–768. 2011.PubMed/NCBI
|
|
12
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roessler S, Long EL, Budhu A, Chen Y, Zhao
X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, et al: Integrative
genomic identification of genes on 8p associated with
hepatocellular carcinoma progression and patient survival.
Gastroenterology. 142:957–966. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoshida Y, Nijman SM, Kobayashi M, Chan
JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K,
Hashimoto M, et al: Integrative transcriptome analysis reveals
common molecular subclasses of human hepatocellular carcinoma.
Cancer Res. 69:7385–7392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaposi-Novak P, Libbrecht L, Woo HG, Lee
YH, Sears NC, Coulouarn C, Conner EA, Factor VM, Roskams T and
Thorgeirsson SS: Central role of c-Myc during malignant conversion
in human hepatocarcinogenesis. Cancer Res. 69:2775–2782. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue W, Krasnitz A, Lucito R, Sordella R,
Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers
S, et al: DLC1 is a chromosome 8p tumor suppressor whose loss
promotes hepatocellular carcinoma. Genes Dev. 22:1439–1444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beer S, Zetterberg A, Ihrie RA, McTaggart
RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B,
et al: Developmental context determines latency of MYC-induced
tumorigenesis. PLoS Biol. 2:e3322004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zimonjic DB and Popescu NC: Role of DLC1
tumor suppressor gene and MYC oncogene in pathogenesis of human
hepatocellular carcinoma: Potential prospects for combined targeted
therapeutics (review). Int J Oncol. 41:393–406. 2012.PubMed/NCBI
|
|
19
|
Guan M, Tripathi V, Zhou X and Popescu NC:
Adenovirus-mediated restoration of expression of the tumor
suppressor gene DLC1 inhibits the proliferation and tumorigenicity
of aggressive, androgen-independent human prostate cancer cell
lines: Prospects for gene therapy. Cancer Gene Ther. 15:371–381.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan BZ, Zhou X, Durkin ME, Zimonjic DB,
Gumundsdottir K, Eyfjord JE, Thorgeirsson SS and Popescu NC: DLC-1
gene inhibits human breast cancer cell growth and in vivo
tumorigenicity. Oncogene. 22:445–450. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang X, Popescu NC and Zimonjic DB: DLC1
interaction with S100A10 mediates inhibition of in vitro cell
invasion and tumorigenicity of lung cancer cells through a
RhoGAP-independent mechanism. Cancer Res. 71:2916–2925. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan CH, Lee SW, Li CF, Wang J, Yang WL,
Wu CY, Wu J, Nakayama KI, Kang HY, Huang HY, et al: Deciphering the
transcriptional complex critical for RhoA gene expression and
cancer metastasis. Nat Cell Biol. 12:457–467. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Du H and Zhai G: Recent advances
in active hepatic targeting drug delivery system. Curr Drug
Targets. 15:573–599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Treichel U, Meyer Zum Büschenfelde KH,
Stockert RJ, Poralla T and Gerken G: The asialoglycoprotein
receptor mediates hepatic binding and uptake of natural hepatitis B
virus particles derived from viraemic carriers. J Gen Virol.
75:3021–3029. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reig M, Darnell A, Forner A, Rimola J,
Ayuso C and Bruix J: Systemic therapy for hepatocellular carcinoma:
The issue of treatment stage migration and registration of
progression using the BCLC-refined RECIST. Semin Liver Dis.
34:444–455. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mikhail S, Cosgrove D and Zeidan A:
Hepatocellular carcinoma: Systemic therapies and future
perspectives. Expert Rev Anticancer Ther. 14:1205–1218. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Albihn A, Johnsen JI and Henriksson MA:
MYC in oncogenesis and as a target for cancer therapies. Adv Cancer
Res. 107:163–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McKeown MR and Bradner JE: Therapeutic
strategies to inhibit MYC. Cold Spring Harb Perspect Med.
4:a0142662014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jaffe AB and Hall A: Rho GTPases:
Biochemistry and biology. Annu Rev Cell Dev Biol. 21:247–269. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grise F, Bidaud A and Moreau V: Rho
GTPases in hepatocellular carcinoma. Biochim Biophys Acta.
1795:137–151. 2009.PubMed/NCBI
|
|
31
|
Wong CM, Lee JM, Ching YP, Jin DY and Ng
IO: Genetic and epigenetic alterations of DLC-1 gene in
hepatocellular carcinoma. Cancer Res. 63:7646–7651. 2003.PubMed/NCBI
|
|
32
|
Healy KD, Hodgson L, Kim TY, Shutes A,
Maddileti S, Juliano RL, Hahn KM, Harden TK, Bang YJ and Der CJ:
DLC-1 suppresses non-small cell lung cancer growth and invasion by
RhoGAP-dependent and independent mechanisms. Mol Carcinog.
47:326–337. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong CM, Yam JW, Ching YP, Yau TO, Leung
TH, Jin DY and Ng IO: Rho GTPase-activating protein deleted in
liver cancer suppresses cell proliferation and invasion in
hepatocellular carcinoma. Cancer Res. 65:8861–8868. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qian X, Li G, Asmussen HK, Asnaghi L, Vass
WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG and Lowy DR:
Oncogenic inhibition by a deleted in liver cancer gene requires
cooperation between tensin binding and Rho-specific
GTPase-activating protein activities. Proc Natl Acad Sci USA.
104:9012–9017. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Berenjeno IM, Núñez F and Bustelo XR:
Transcriptomal profiling of the cellular transformation induced by
Rho subfamily GTPases. Oncogene. 26:4295–4305. 2007. View Article : Google Scholar : PubMed/NCBI
|
